Eli Hurvitz of Teva Pharmaceutical Industries: From pennies to profits - Israel's generic-drug powerhouse may not be large by global pharmaceuticals standards, but it has learned to use every edge it can find.
Year of publication:
Institutional investor. - New York, NY : Institutional Investor Inc., ISSN 0192-5660, ZDB-ID 3955412. - Vol. 23.1998, 2, p. 29-30